Portfolio (Quarterly)
Guide ↗
Candriam S.C.A.
· CIK 0001537014| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 101 | HCA | HCA HEALTHCARE INC | Healthcare | 99,102.0 | $42.2M | 0.22% | NEW | — | $426.20 | -11.1% |
| 102 | LAUR | LAUREATE EDUCATION INC | Consumer Defensive | 1,329,851.0 | $41.9M | 0.22% | NEW | — | $31.54 | +21.4% |
| 103 | CGON | CG ONCOLOGY INC | Healthcare | 1,037,892.0 | $41.8M | 0.22% | NEW | — | $40.28 | +82.9% |
| 104 | PYPL | PAYPAL HLDGS INC | Financial Services | 623,059.0 | $41.8M | 0.22% | NEW | — | $67.06 | -18.3% |
| 105 | WDC | WESTERN DIGITAL CORP | Technology | 346,141.0 | $41.6M | 0.22% | NEW | — | $120.06 | +318.2% |
| 106 | RL | RALPH LAUREN CORP | Consumer Cyclical | 131,817.0 | $41.3M | 0.22% | NEW | — | $313.56 | +19.6% |
| 107 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 868,724.0 | $40.6M | 0.21% | NEW | — | $46.70 | +295.4% |
| 108 | BMY | BRISTOL-MYERS SQUIBB CO | Healthcare | 897,263.0 | $40.5M | 0.21% | NEW | — | $45.10 | +29.4% |
| 109 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 287,645.0 | $40.4M | 0.21% | NEW | — | $140.38 | +22.4% |
| 110 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 611,237.0 | $40.0M | 0.21% | NEW | — | $65.42 | -17.0% |
| 111 | DDOG | DATADOG INC | Technology | 272,170.0 | $38.8M | 0.20% | NEW | — | $142.40 | +84.4% |
| 112 | CTAS | CINTAS CORP | Industrials | 179,586.0 | $36.9M | 0.19% | NEW | — | $205.26 | -6.5% |
| 113 | AEM | AGNICO EAGLE MINES LTD | Basic Materials | 218,303.0 | $36.8M | 0.19% | NEW | — | $168.46 | -16.1% |
| 114 | MDLZ | MONDELEZ INTL INC | Consumer Defensive | 588,417.0 | $36.8M | 0.19% | NEW | — | $62.47 | -6.0% |
| 115 | AMAT | APPLIED MATLS INC | Technology | 179,467.0 | $36.7M | 0.19% | NEW | — | $204.74 | +177.9% |
| 116 | EGO | ELDORADO GOLD CORP NEW | Basic Materials | 1,270,400.0 | $36.7M | 0.19% | NEW | — | $28.89 | +0.2% |
| 117 | XOM | EXXON MOBIL CORP | Energy | 318,725.0 | $35.9M | 0.19% | NEW | — | $112.75 | +26.9% |
| 118 | PNC | PNC FINL SVCS GROUP INC | Financial Services | 178,811.0 | $35.9M | 0.19% | NEW | — | $200.93 | +26.8% |
| 119 | — | ASCENDIS PHARMA A/S | — | 178,956.0 | $35.6M | 0.19% | NEW | — | $198.81 | — |
| 120 | ARGX | ARGENX SE | Healthcare | 48,200.0 | $35.6M | 0.19% | NEW | — | $737.56 | +17.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
36.7%
Healthcare
22.2%
Financial Services
11.6%
Consumer Cyclical
7.9%
Communication Services
7.0%
Industrials
5.9%
Consumer Defensive
3.0%
Basic Materials
1.6%
Real Estate
1.6%
Utilities
1.6%